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During embryonic development, the foundation of the germline is laid by the
specification of primordial germ cells (PGCs) from the postimplantation epi-
blast via bone morphogenetic protein (BMP) and WNT signalling. While the
majority of epiblast cells undergo differentiation towards somatic cell lineages,
PGCs initiate a unique cellular programme driven by the cooperation of the
transcription factors BLIMP1, PRDM14 and AP2g. These factors syner-
gistically suppress the ongoing somatic differentiation and drive the
re-expression of pluripotency and germ cell-specific genes accompanied by
global epigenetic changes. However, an unresolved question is how postim-
plantation epiblast cells acquire the developmental competence for the PGC
fate downstream of BMP/WNT signalling. One emerging concept is that tran-
scriptional enhancers might play a central role in the establishment of
developmental competence and the execution of cell fate determination.
Here, we discuss recent advances on the specification and reprogramming of
PGCs thereby highlighting the concept of enhancer function.1. Introduction
Primordial germ cells (PGCs), the precursors of the gametes, represent a cell
lineage with unique properties. They are unipotent and differentiate into
sperm and oocytes, depending on the sex of the organism. Fertilization of the
oocyte by sperm generates the totipotent zygote, which is the founder cell of
all lineages of an organism. In addition, PGCs in culture can give rise to plur-
ipotent embryonic germ cells [1,2], which closely resemble embryonic stem (ES)
cells [3]. Thus, the PGC lineage differentiates and at the same time acquires the
capacity to become totipotent.
Mammals specify their PGCs in response to instructive signalling during
embryonic development. In mice, the blastocyst differentiates into epiblast,
trophectoderm and primitive endoderm (figure 1). The epiblast develops into
the embryo proper, whereas the other two lineages give rise to extraembryonic
tissues. The latter not only develop into essential structures such as the placenta
to support the development of the embryo but also act as signalling sources to
allocate lineages to the epiblast cells. Bone morphogenetic protein (BMP) signal-
ling at embryonic day (E) 6.25 after implantation from the extraembryonic
tissue to the proximal epiblast results in the specification of the germ cell lin-
eage, by assigning a few epiblast cells to become PGCs [4,5]. While the
remaining epiblast cells initiate differentiation towards somatic cell lineages,
nascent PGCs reverse this programme by switching on the expression of a
transcriptional network including BLIMP1, PRDM14 and AP2g [6–8]. These
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Figure 1. Embryonic origin of PGCs in vivo and PGC derivation in vitro. The preimplantation blastocyst at E4.5 consists of the embryonic lineage, the epiblast, and
two extraembryonic lineages, primitive endoderm and trophectoderm. After implantation at E6.5, signalling from the extraembryonic ectoderm as well as from the
visceral endoderm induces a few cells of the proximal epiblast to become PGCs. In vitro, ES cells, which are derived from the preimplantation epiblast, can be
differentiated into epiblast-like cells (EpiLCs) with Activin A and basic fibroblast growth factor. EpiLCs, in turn, respond to BMP4 to give rise to functional
PGC-like cells. Epiblast stem cells (EpiSCs), which are traditionally derived from the postimplantation epiblast, also give rise to PGC-like cells, but at a low frequency.
(Online version in colour.)
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ling in part by inducing the re-expression of pluripotency
genes and repressing the DNA methylation machinery,
accompanied by genome-wide DNA demethylation, X
chromosome reactivation, erasure of imprints and dynamic
changes in histone modification signatures [9–14]. During
this reprogramming event, PGCs proliferate and migrate
towards the genital ridges, which they colonize by E10.5.
Female PGCs enter meiosis at approximately E12.5 to pro-
duce oocytes, and male PGCs induce a mitotic arrest at
approximately E13.5 before they undergo spermatogenesis.
At the time of PGC specification, postimplantation epiblast
cells exhibit a state of primed pluripotency; they express some
pluripotency-associated genes together with lineage commit-
ment genes. Moreover, these cells show signs of differentiation
such as DNA methylation and an inactive X chromosome (in
female embryos) [15–19].Although theyare able todifferentiate
into all embryonic cell lineages, they do not contribute to chi-
maeras when injected into blastocysts. So far, all attempts to
directly differentiate PGCs in vitro from pluripotent cell types
that are distinct from the postimplantation epiblast worked at
extremely low efficiency or have failed altogether. The question
of how postimplantation epiblast cells gain the developmental
potential to become PGCs remains unclear.
One emerging concept is that enhancer elements play a
pivotal role in defining or at least contributing to the establish-
ment of developmental potential. Enhancer elements can be
defined as cis- (and in a few cases trans-) acting DNA
sequences that contain multiple transcription factor binding
sites, which activate transcription of associated genes indepen-
dent of their location, orientation or distance relative to gene
promoters. Intriguingly, enhancers exhibit cell type-specific
patterns of combinatorial histone modifications, whichcorrelate with their activity. Inactive enhancers also carry a
specific epigenetic signature in progenitor cells before they
become activated upon signalling, which led to the hypothesis
that enhancers exist in a ‘poised’ state prior to their activation.
Thus, the epigenetic set-up of enhancers might also be a
prerequisite for the gradual process of lineage commitment
and differentiation in the context of PGC specification from
postimplantation epiblast cells.
In this review, we will discuss the specification and repro-
gramming of PGCs and, in particular, the principles of
enhancer function with examples from different systems.2. Induction of the primordial germ cell fate
The germ cell lineage is formed via distinct modes in the
animal kingdom. Some species such as Caenorhabditis elegans or
Xenopus laevis rely on maternally inherited determinants,
which segregate asymmetrically to the prospective PGCs [20].
Other species, including mammals, specify their PGCs in
response to signalling during embryonic development. Indeed,
some invertebrates such as the cricket Gryllus bimaculatus also
induce PGCs through BMP signalling [21,22]. In mice, BMP
signalling is required for mesoderm development and PGC
specification. BMP4 and BMP8b secreted from the extraembryo-
nic ectoderm at E6.0 towards the proximal epiblast induce a few
cells in the posterior of the embryo to become PGCs (figure 1)
[4,5,23]. BMP4 is sufficient to induce PGCs,whereas BMP8b con-
trols thedevelopmentof thevisceral endoderm,which is a source
of inhibitory signals including LEFTY1 andCER1 for BMP4 [24].
BMP2 is expressed in the visceral endoderm, which surrounds
the epiblast, and presumably augments the BMP4 signal in the
posterior of the embryo [24,25]. The BMP4 signal acts through
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Figure 2. The role of BMP and WNT signalling in PGC specification. BMP4 emanating from the extraembryonic ectoderm and BMP2 from the visceral endoderm
induce the phosphorylation of SMAD1 and SMAD5, which form a complex with SMAD4. This complex translocates into the nucleus and presumably binds enhancers
and promoters of genes that are required to establish PGC fate. Moreover, BMP signalling results in the direct or indirect activation of WNT3, which is also required to
induce the PGC fate. Most likely, WNT3 signalling results in the repression of GSK3, which in turn causes the stabilization of b-CATENIN. b-CATENIN translocates into
the nucleus and together with LEF1/TCF activates the expression of T-Brachyury. T-BRACHYURY binds to enhancers which are in close proximity to the promoters of
Prdm1 (encoding BLIMP1) and Prdm14. (Online version in colour.)
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which results inSMAD1/5phosphorylation (figure 2). SMAD1/
5 form a complex with SMAD4 and translocate to the nucleus to
control target gene expression. The importance of this pathway is
demonstrated by studies withmutations in Bmp4, Bmp8b, Smad1
and Smad5 as they show impaired PGC development [5,26,27].
The exact target genes of the BMP pathway in the prospective
PGCs remain to be identified. However, BMPs trigger the acti-
vation of a transcriptional network with the key regulators
BLIMP1 and PRDM14, while AP2g is induced by BLIMP1
[28,29]. This is followed by the re-expression of pluripotency
genes such as Nanog and Sox2.
BMP signalling is also required in a dose-dependent
manner for maintaining pluripotency of ES cells [30]. ChIP-
seq (chromatin immunoprecipitation followed by massively
parallel sequencing) studies for a number of transcription fac-
tors in ES cells revealed that the BMP target SMAD1 together
with OCT4, SOX2, NANOG and STAT3 co-bind loci that are
mainly in intergenic regions, where enhancers reside, to drive
ES-specific gene expression [31]. Some of these factors also pro-
mote the recruitment of p300, a transcriptional co-activator and
histone acetyltransferase known to bind to enhancers [32].
Thus, SMAD1, the downstreammediator of the BMP pathway,
cooperates with additional transcriptional factors to bind
to enhancers in a combinatorial way to execute the ES cell
programme. Of note, the binding of these factors is interdepen-
dent, as the knockdown of individual proteins reduces the
binding affinity of their partners [31]. This provides one expla-
nation for the basic question of how the same transcription
factors in different combinations regulate distinct cellular iden-
tities. Accordingly, a study on the haematopoietic lineage
shows that SMAD1 together with TCF712, a transcription
factor mediating WNT signalling, co-occupies enhancers in
haematopoietic stem cells [33]. Upon erythropoiesis, thebinding of these factors gets directed to a narrower set of
enhancers, which are occupied by the lineage-specific GATA
factors, refining the transcriptional output. Thus, SMAD1
binds specific subsets of enhancers in a context-dependent
manner and it will be of particular interest to identify the
SMAD1/5 targets and its partners acting to initiate the PGC
programme.
A second signalling pathway that is required for the
induction of PGCs is the WNT pathway mediated by
WNT3/b-CATENIN (figure 2) [34]. Wnt3 is expressed at
first in the posterior visceral endoderm at about E5.5, and
then additionally in the posterior epiblast at approximately
E5.75 [35], which precedes the time of PGC specification. A
mutation inWnt3 results in defects in gastrulation and primi-
tive streak formation [36], andmutant epiblasts fail to give rise
to PGCs [24]. One of the downstream targets of WNT3 is
the T gene, which encodes the T-box transcription factor
T-BRACHYURY, and its role in mesoderm formation has
been extensively described [37]. A recent study revealed that
T-BRACHYURY expression is also essential and sufficient
for PGC specification [34]. T-BRACHYURY binds to putative
enhancers that are in close proximity to Prdm1 and Prdm14,
but further studies are required to determine whether this
binding directly activates the expression of these genes.
Although many functionally characterized enhancers are in
close proximity to their target promoters, a few examples
exist of long-range interactions such as the enhancer of Sonic
hedgehog, which is located approximately 1 Mb away in an
intron of the Lmbr1 gene [38]. Indeed, new emerging technol-
ogies such as chromosome conformation capture (3C) in
combination with next generation sequencing (4C, 5C, Hi-C)
or ChIA-PET (chromatin interaction analysis by paired-end
tag sequencing) revealed that the majority of enhancers do
not target the nearest promoter [39,40].
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Figure 3. Model of the enhancer set-up during differentiation. During differentiation, a set of neutral enhancers changes its epigenetic profile and become poised
for activation. These enhancers can be engaged by factors downstream of signalling pathways, activating them to induce the transcriptional programme of a specific
differentiation programme. (Online version in colour.)
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two distinct lineages from the same set of progenitor epiblast
cells, the mesodermal and PGC lineage. There appears to be
an intricate balance between the timing of signalling events
and the precise order in which they act to induce target
gene expression. For example, priming of cultured epiblast
cells (see below) with WNT prior to BMP exposure inhibits
the induction of the PGC fate [34]. The activation of BMP
signalling thus seems to be required in prospective PGCs to
provide competence for WNT-mediated induction of the
PGC fate through T-BRACHYURY.3. Developmental competence to become
primordial germ cells
During embryonic development, only a few cells of the prox-
imal epiblast are destined to become PGCs. However, early
experiments suggested that not only the proximal epiblast
cells exhibit the developmental competence for PGC fate
acquisition. Distal epiblast cells could also respond to BMP
signalling and adopt the PGC fate when transplanted poster-
iorly to the proximal epiblast adjacent to the BMP signal
emanating from the extraembryonic ectoderm [41,42]. More
recently, it was shown that the majority of cells of the
epiblast, separated from the visceral endoderm and/or extra-
embryonic ectoderm, can adopt the PGC fate upon addition
of BMP4 to the culture medium [24], which shows that
most postimplantation epiblast cells are generally competent
to become PGCs. However, this competence exists only for a
short duration during development in the epiblast from E5.5
to E6.5 embryos. In part this is due to inhibitory signals from
the visceral endoderm, including CER1, LEFTY1 and DKK1
that inhibit posteriorization and consequently restrict the spe-
cification of the PGC fate to the posterior proximal epiblast.
Accordingly, Smad22/ – embryos that lack the BMP inhibitor
CER1 fail to restrict PGC induction [24].
Cells fromthepostimplantation epiblast cangive rise to self-
renewing andpluripotent epiblast stemcells (EpiSCs) in culture
under appropriate culture conditions. Traditionally, this cell
type was derived from the epiblast of E5.5–E6.5 embryos
[43,44], but more recently EpiSCs were also successfully
derived from E3.5 preimplantation embryos and from E6.5 to
E8.0 embryos [45,46]. EpiSCs in some ways resemble in vivo
postimplantation epiblast cells as they also show higher
expression of lineage-determining genes such as Fgf5 and
Lefty1 aswell as lower expressionof pluripotencygenes as com-
pared with ES cells and exhibit an inactivate X chromosome in
female cells. EpiSCs retain the capability to become PGC-like
cells in vitro [47]. They express BMP4 and continuously specifyPGC-like cells under self-renewing conditions, but at very low
frequency. It was recently shown that EpiSCs are very similar
to the ectoderm of the late gastrula stage irrespective of the
developmental stages they were derived from [48]. Thus,
EpiSCs reflect a later developmental stage compared to that
when PGCs are specified in vivo, which could explain the low
efficiency of PGC derivation in vitro.
The appropriate conditions to efficiently derive PGCs
directly from ES cells in vitro are not yet identified. However,
when ES cells are injected into blastocysts, they can contrib-
ute to all embryonic lineages including the germline and
under certain culture conditions even give rise to extraem-
bryonic lineages [49,50]. Thus, it could be that ES cells must
transit to a primed epiblast-like state first as in vivo, before
they gain the competence to efficiently give rise to PGCs in
vitro. Indeed, such a two-step differentiation method was
recently developed (figure 1) [51,52]. ES cells were differen-
tiated into epiblast-like cells (EpiLCs) using Activin A and
basic fibroblast growth factor (FGF), the same cytokines used
to culture EpiSCs under self-renewing conditions. After 2
days of differentiation, EpiLCs exhibit a similar transcriptional
profile to postimplantation epiblasts from E5.75 embryos [51],
which corresponds to the developmental stage, when they
become competent to induce the PGC fate. EpiLCs then
respond to BMP4 by giving rise to functional PGC-like cells
at high frequency.
WNT3 signalling is required for the competence of the
epiblast cells to induce germline determinants downstream of
BMP4 and subsequently give rise to PGCs [24,34]. PGC-like
cells can be derived fromWnt3mutant EpiLCs via overexpres-
sion of T-BRACHYURY, which suggests that WNT3 induces
the PGC fate directly, where T-BRACHYURY is activated by
b-CATENIN downstream of WNT3 (figure 2) [34]. Interest-
ingly, in the absence of BMP signalling, T-BRACHYURY fails
to induce BLIMP1 and PRDM14, indicating that BMP4 is
required for the competence of epiblast cells to respond to
WNT signalling to induce the PGC fate. This collaboration
between WNT and BMP signalling indicates a more complex
scenario than previously anticipated.
One concept that needs functional testing is whether
enhancers are set up via a cell type-specific histone modifi-
cation signature in order to prime them for activation,
thereby contributing to the developmental potential of a
cell type (figure 3). Enhancer usage is a dynamic process
during differentiation as exemplified by the gene Pou5f1
(encoding OCT4), which is alternately under the control of
its distal and proximal enhancers depending on the develop-
mental context [53]. The preimplantation epiblast, ES cells
and PGCs engage the distal enhancer for Pou5f1 expression,
whereas the postimplantation epiblast and EpiSCs make
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Figure 4. Epigenetic reprogramming of PGCs. Upon specification of PGCs at E6.5, a PGC-specific transcriptional network including BLIMP1, PRDM14 and AP2g is
activated. PRDM14 binds predominantly to enhancers, whereas BLIMP1 occupies mainly promoters. AP2g shows bimodal enrichment and binds to both distal
regulatory elements as well as promoters. These transcription factors synergistically repress somatic and proliferation genes and the expression of some epigenetic
regulators. Further, they activate the expression of another set of epigenetic regulators as well as germ cell genes. These transcriptional changes are accompanied by
epigenetic remodelling: H3K9me2 is progressively lost, H3K27me3 is enriched and DNA is globally demethylated. These epigenetic changes could potentially
contribute to the remodelling of the enhancer landscape towards the capacity of totipotency. (Online version in colour.)
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utilization for Pou5f1 has been exploited extensively for the
experimental manipulation of PGCs, and it is interesting to
speculate that it is a marker of global alterations of enhancer
engagement as PGC specification commences. Moreover,
recent studies show that enhancers exhibit a defined set of
histone modifications during differentiation. For example,
H3K4me1 and H3K27ac mark an active set of enhancers in
human ES cells, whereas primed or ‘poised’ enhancers are
marked by H3K4me1 and H3K27me3, which are associated
with developmental genes [55]. Upon differentiation of
human ES cells into neuroectodermal spheres, a subset of
poised enhancers become activated and change their epige-
netic profile by losing H3K27me3 but gaining H3K27ac.
There is accumulating evidence that these histone modifi-
cations are indeed causative for enhancer activity and not
just a consequence [56]. For example, the TALEN system
was used to recruit the histone demethylase LSD1 to target
enhancers to remove H3K4 methylation, which resulted in
a decrease in their activity [57]. In addition, the histone
methyltransferase MLL4 was shown to catalyse the depo-
sition of H3K4me1 at enhancers in a tissue-specific manner
during adipogenesis and myogenesis [58]. Thus, the set-up
of the enhancer landscape might potentially contribute to
the establishment of developmental competence during the
initiation of differentiation from the inner cell mass of the
blastocyst towards the postimplantation epiblast prior to
PGC specification.4. The primoridal germ cell-specific
transcriptional network
Upon BMP signalling, prospective PGCs sequentially activate
the expression of the three key transcription factors BLIMP1,
PRDM14, followed by AP2g. Although these factors in combi-
nation set up the initial condition required for reprogramming
of PGCs, each one of them is also involved in other processes
and expressed in distinct tissues: BLIMP1 has been well charac-
terized in the functional differentiation of B and T lymphocytes
and other haematopoietic lineages as well as in the epidermis,
with various different functions during development [59–62];
PRDM14 is required for maintaining naive pluripotency in ES
cells by repressing FGF signalling and DNA methylation
[63,64]; AP2g is involved in the development of extraembryonic
tissues among others [65]. However, their combined presence
results in the emergent properties of nascent PGCs when
expressed at the correct developmental time point [28,29].
In prospective PGCs, the three factors execute changes in
different branches of the gene expression programme (figure 4)
[28]. Firstly, they suppress the ongoing somatic differentiation
through repressing the expression of somatic regulators. Sec-
ondly, they repress genes required for DNA methylation, thus
enabling DNA demethylation. Furthermore, they slow down
cell proliferation by repressing genes essential for cell cycle
progression and cell growth. Simultaneously, they induce
PGC-specific gene expression by driving the reinstatement of a
subset of the pluripotency network concurrent with the
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Dnd1. Inaddition, these factorsdifferentially regulate several his-
tonemodifiers such asKdm6b,Kdm3a andKdm4b that act to alter
the chromatin state of nascent PGCs. Remarkably, the three
factors can completely substitute for cytokines and are sufficient
for the induction of the PGC fate from EpiLCs in culture [28,29].
Individual factors were able to also induce the PGC fate but
at decreased efficiencies, and the resulting PGCs always induced
the expression of the remaining factors [29]. In fact, genetic
experiments have shown that all three factors are essential for
PGC development in vivo [6–8], which most likely is also the
case in vitro.
Interestingly, BLIMP1, PRDM14 and AP2g have distinct
binding patterns relative to promoters. BLIMP1 is mainly
enriched at transcriptional start sites, whereas PRDM14 is
predominantly bound to enhancers (figure 4) [28,66]. These
two factors are thus likely to collaborate on the regulation
of gene expression through distinct mechanisms. AP2g, on
the other hand, appears to bridge this relationship by show-
ing bimodal enrichment, both on distal regulatory elements
as well as on promoters. This binding pattern exhibited by
these three essential factors underscores the importance of
regulating gene expression both at the level of enhancers as
well as promoters when driving cellular commitment. In
fact, BLIMP1 is mainly responsible for direct gene repression,
with some notable exceptions, and collaborates in repressing
somatic genes with the other two factors. It thus seems likely
that the most efficient way of repressing gene expression is by
directly repressing promoter activity, whereas the activation
of robust gene expression de novo is likely to require enhancer
engagement and activation.
Interestingly, OCT4 along with SOX2 and KLF4 has been
shown to exhibit pioneer factor function during somatic cell
reprogramming, where they co-bind a large set of DNAse-I
inaccessible sites that are devoid of histone modifications
[67]. Pioneer transcription factors have the ability to bind to
DNA sequences recruiting cofactors, causing chromatin
remodelling and rendering the site accessible to other factors
[68,69]. The binding of OCT4, SOX2 and KLF4 is a prerequi-
site for the binding of Myc, which in turn enhanced the
binding of the other three, showing that indeed OCT4,
SOX2 and KLF4 act as pioneer factors to initiate reprogram-
ming and access enhancers that have been rendered inactive
by heterochromatization, preceding downstream changes in
transcriptional activity [67]. The action of the three PGC spe-
cifying factors BLIMP1, PRDM14 and AP2g is highly context
dependent, suggesting that they are unlikely to function as
pioneer factors. OCT4 is present both in ES cells and in the
PGC competent state of the primed pluripotent epiblast
cells and thus is also not likely to act as a pioneer factor
allowing the subsequent binding of the three factors to their
PGC target sites. Whether there exist other factors that can
act as pioneer factors for priming the action of the tripartite
network for PGC induction remains to be addressed.5. Epigenetic reprogramming of primordial
germ cells
The transcriptional changes that are initiated after PGC speci-
fication are connected to extensive and dynamic epigenetic
reprogramming including global DNA demethylation and
changes in the profile of histone modifications (figure 4)[9–14]. Generally, DNA methylation at cytosines (5-methyl-
cytosine; 5mC) regulates chromatin structure as well as
gene transcription to stabilize a cell lineage-specific gene
expression profile. During embryonic development, its
genome wide erasure and reinstatement correlates with
gain of developmental competence and lineage determi-
nation, respectively [70]. Shortly after PGC specification at
E8.5–E12.5, the global erasure of DNA methylation resets
the epigenome of PGCs including genomic imprints. The
latter are subsequently re-established gender specifically
and passed on to the next generation, giving rise to the
monoallelic expression of imprinted genes in a parent-of-
origin-specific manner [71]. Furthermore, methylation-
dependent genes that are expressed specifically in the germ-
line, such as Dazl, Ddx4 and Rhox genes, become activated
[72–74]. It is tempting to speculate that global DNA demethy-
lation in PGCs contributes to a switch in the enhancer usage to
establish the germline-specific gene expression programme.
Several studies suggest a functional relationship of enhancers
and DNAmethylation, as enhancer activity inversely correlates
with DNA methylation. Differentially methylated regions
identified via the generation of DNA methylation maps using
a number of adult mouse tissues were predominantly located
at putative enhancer elements [75]. Furthermore, active
enhancers marked with H3K4me1 and H3K27ac in ES cells
show enrichment of 5-hydroxymethylation (5-hydroxy-
methylcytosine; 5hmC [76–78], an intermediate in the DNA
demethylation pathway). Intriguingly, global DNA demethyla-
tion in PGCs is driven in part by TET1 and TET2,which catalyse
the conversion of 5mC to 5hmC, which is then removed via
DNA replication-coupled dilution [14]. Thus, the erasure of
DNA methylation could potentially open up the opportunity
to activate a new set of enhancers.
Of note, at the time of global DNA demethylation,
PRMT5, an arginine methyltransferase, translocates from
the cytoplasm to the nucleus specifically in PGCs [79].
PRMT5 catalyses the methylation of H2A/H4R3me2, but its
functional importance in PGCs remains to be investigated.
DNA demethylation in PGCs takes place in concert with
dynamic global changes in histone modifications. There is a
progressive loss of H3K9me2 at E7.75–E8.75 [10,11,13], which
can be due to the repression of the methyltransferase GLP.
It is unlikely that the erasure of H3K9me2 is due to a passive
dilution during DNA replication, since the PGC-specific tran-
scriptional network represses proliferation factors [28], and
PGCs undergo a G2 arrest during this developmental period
[11]. Thus, an induction of demethylases and/or the replace-
ment of the entire histone H3 molecule by its non-canonical
counterpart H3.3 are presumably involved in this event. In
parallel, fromE8.25 until E9.5, H3K27me3, amark that is depos-
ited by polycomb repressive complex 2 (PRC2), progressively
increases in PGCs and changes in distribution from being con-
centrated on the inactive X chromosome in female embryos to
having a more even distribution throughout the nucleus
[10,11,13]. The functional implications of these changes are
unclear because both histone marks are associated with tran-
scriptional repression and it would be interesting to see which
loci lose or gain these marks over time. Notably, a recent
study analysed local enrichment of histone modifications via
low cell number chromatin immunoprecipitation using PGCs
at different developmental time points (E11.5, E13.5 and
E15.5), identifying a germ cell-specific set of active enhancers
[80]. Moreover, H3K27me3 seems to be enriched not only at
rstb.royalsocietypublishing
7
 on August 3, 2015http://rstb.royalsocietypublishing.org/Downloaded from developmental genes but also at genes involved in immune
system activation, which were germ cell specific when com-
pared to other cell types including ES cells. Although further
studies are required to clarify the underlying mechanisms
and the functional implications of epigenetic reprogramm-
ing during PGC development, it seems that PGCs acquire a
unique epigenetic set-up that most likely shapes the enhancer
landscape by activating, poising or inactivating them in
preparation for totipotency..org
Phil.Trans.R.Soc.B
369:201305436. Concluding remarks
With the advent of a novel culture system for PGC induction,
molecular events driving the specification and differentiation
of this unique cell lineage are being uncovered at an ever
increasing pace. Systematic investigations have revealed a
precise order of signalling events required for the arrest of
mesodermal induction simultaneous to the retention of under-
lying pluripotency and the push towards the unipotent state of
developing PGCs that undergo an epigenetic re-setting event
prior to meiosis or spermatogenesis. Although these events
have been extensively studied and well described, we arestill at the beginning of understanding the underlyingmechan-
isms and their functional implications. The fact that even the
powerful combination of the three transcription factors
BLIMP1, PRDM14 and AP2g is not sufficient for inducing
this cell fate until the correct developmental window is reached
in the pluripotent postimplantation epiblast cells or their
in vitro counterpart has opened up further questions of
developmental plasticity and competence.
We have here described molecular events shaping the pro-
cess of PGC specification and reprogramming with a specific
perspective on the role of transcriptional enhancers in cell fate
specification. The concept that the epigenetic state of enhancers
defines or at least contributes to developmental competence
remains to be elucidated and functional studies are required to
identify the true nature of their role in development.Acknowledgements. We thank Jamie Hackett for critical reading of the
manuscript.
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